Trial Profile
Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Apr 2017
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Coronary artery disease; Stent thrombosis
- Focus Therapeutic Use
- Acronyms IDEAL-PCI
- 01 Feb 2012 New trial record